Osaic Holdings’s Janux Therapeutics JANX Stock Holding History

Osaic Holdings’s Portfolio JANX Stock Details JANX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.21K	Sell	404 -32	-7%	-$464	﹤0.01%	6827
2026 Q1	$6.06K	Buy	436 +158	+57%	+$2.17K	﹤0.01%	6585
2025 Q4	$3.84K	Sell	278 -3,512	-93%	-$82.6K	﹤0.01%	6838
2025 Q3	$90.2K	Buy	3,790 +322	+9%	+$7.84K	﹤0.01%	4877
2025 Q2	$80.1K	Buy	3,468 +3,037	+705%	+$80K	﹤0.01%	4680
2025 Q1	$11.6K	Sell	431 -2,804	-87%	-$106K	﹤0.01%	5707
2024 Q4	$173K	Buy	3,235 +2,067	+177%	+$109K	﹤0.01%	3729
2024 Q3	$53.1K	Buy	1,168 +65	+6%	+$2.83K	﹤0.01%	4703
2024 Q2	$46.2K	Buy	1,103 +758	+220%	+$35.6K	﹤0.01%	4744
2024 Q1	$13K	Buy	+345	New	+$7.51K	﹤0.01%	5610

Other funds holding JANX

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Osaic Holdings's JANX Position: Q2 2026 in Review

Osaic Holdings reduced its Janux Therapeutics (JANX) stake by 7.3% in Q2 2026, selling an estimated $464 and leaving 404 shares worth $6.21K. The position accounts for ﹤0.01% of the portfolio, ranked #6827.

Osaic Holdings first reported a position in JANX in Q1 2024 and has held it in 10 quarters since. The position peaked at $173K in Q4 2024. 197 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

Osaic Holdings held 404 shares of Janux Therapeutics worth $6.21K as of Q2 2026.
Osaic Holdings sold 32 Janux Therapeutics shares in Q2 2026, an estimated $464.
Janux Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6827 holding.
Osaic Holdings first reported a position in Janux Therapeutics in Q1 2024 and has held it in 10 quarters since.
Osaic Holdings's Janux Therapeutics position peaked at $173K in Q4 2024.
197 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.